Yearly Publication Trends - liver diseases

Year	Publication Count
2024	3240
2023	7353
2022	4486
2021	3589
2020	2557
2019	1719
2018	1333
2017	935
2016	1015
2015	670
2014	550

Relevant Publications

Diosgenin attenuates metabolic-associated fatty liver disease through the hepatic NLRP3 inflammasome-dependent signaling pathway.

Issue Release: 2024

Egg white-derived peptides reduced blood glucose in high-fat-diet and low-dose streptozotocin-induced type 2 diabetic mice regulating the hepatic gluconeogenic signaling and metabolic profile.

Issue Release: 2024

Liver enzyme profiles after initiating biological treatment in children with inflammatory bowel diseases.

Issue Release: 2024

The signaling pathways in obesity-related complications.

Issue Release: 2024

LTR Retrotransposon-Derived LncRNA LINC01446 Promotes Hepatocellular Carcinoma Progression and Angiogenesis by Regulating the SRPK2/SRSF1/VEGF Axis.

Issue Release: 2024

Gender-Affirming Hormone Treatment and Metabolic Syndrome Among Transgender Veterans.

Issue Release: 2024

Association between protein-energy malnutrition and healthcare use among adult patients after liver transplantation: A retrospective cohort study.

Issue Release: 2024

Variational autoencoders for generative modeling of drug dosing determinants in renal, hepatic, metabolic, and cardiac disease states.

Issue Release: 2024

Preexisting maternal immunity to AAV but not Cas9 impairs in utero gene editing in mice.

Issue Release: 2024

[Pathophysiology and Diagnostics of Immune Thrombocytopenia].

Issue Release: 2024

Cardiovascular complications during delivery hospitalizations in inflammatory bowel disease patients.

Issue Release: 2024

The Effect of Exercise on Mesenchymal Stem Cells and their Application in Obesity Treatment.

Issue Release: 2024

The lipid side of unfolded protein response.

Issue Release: 2024

The role and mechanism of SUMO modification in liver disease.

Issue Release: 2024

Clinical effects of Hibiscus sabdariffa Linn. on obesity treatment: A systematic review and meta-analysis of randomized controlled trials.

Issue Release: 2024

Novel insights into the potential applications of stem cells in pulmonary hypertension therapy.

Issue Release: 2024

Siglec-H plasmacytoid dendritic cells protects against acute liver injury by suppressing IFN-γ/Th1 response and promoting IL-21 CD4 T cells.

Issue Release: 2024

Innate-like T cells in liver disease.

Issue Release: 2024

Improved liver disease prediction from clinical data through an evaluation of ensemble learning approaches.

Issue Release: 2024

Myocardial infarction accelerates the progression of MASH by triggering immunoinflammatory response and induction of periosti.

Issue Release: 2024

What are Vaccine Side Effects?

Why are Molecular Diagnostics Important for Vaccines?

How are Vaccines Procured and Distributed?

What are the Benefits of Using NGS in Vaccine Development?

Why is Vaccine Education and Training Important?

When Should I Take Acetaminophen After Vaccination?

What Should Patients Do If They Experience High Blood Glucose Levels After Vaccination?

Why are Data Standards Important in Vaccination?

How Do Public Health Campaigns Address Vaccine Hesitancy?

What are Live Attenuated Vaccines?

Partnered Content Networks

Relevant Topics